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Introduction
The United Kingdom has one of the fastest growing rates of 
obesity in the developed world (1). In 2013, approximately 
a quarter of adults (26% of men and 24% of women) were 
obese and 2% were morbidly obese (2). Analysis by the UK 
government estimates that over half of the UK population 
could be obese by 2050, posing a significant challenge to the 
National Health Service (NHS). Obesity causes an increased 
load on the respiratory system (3,4) leading to breathlessness 
and is associated with a number of respiratory conditions 
including asthma, pulmonary embolism, pneumonia and 
obstructive sleep apnea (OSA) (5).
OSA is the most common sleep-related breathing 
disorder, characterized by recurrent episodes of upper 
airway occlusion leading to apneas and hypopneas whilst 
the patient is asleep (6). These episodes cause intermittent 
hypoxia, arousal from sleep and lead to increased 
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sympathetic activity, increased respiratory effort (3,4) and 
sleep fragmentation (7). OSA causes daytime sleepiness 
and has been associated with co-morbidities (8) including 
type 2 diabetes mellitus (T2DM) (9), hypertension (10), and 
increased cardiovascular risks, including stroke (11).
The prevalence of OSA is increasing, it affected 4% of 
middle aged men and 2% of middle aged women in the 
United States in the early 1990’s (12), but with the obesity 
epidemic the prevalence is now at 10% for 30–49-year-old 
men and at 3% for 30–49-year-old women in the US (13). In 
obese subjects, prevalence can be as high as 60-70% (14) and 
most patients remain undiagnosed (15) and untreated (8).
Continuous positive airway pressure (CPAP) is the best 
available treatment for OSA (16), the National Institute of 
Health and Clinical Excellence (NICE) recommends the 
use of CPAP as a treatment option for adults with moderate 
to severe OSA and mandibular advancement devices for 
mild conditions (17). In obese patients, weight loss can 
improve sleep-disordered breathing (18). In severe obesity 
which is refractory to diet, physical exercise and bariatric 
surgery effectively support weight loss (19). However, 
weight loss due to bariatric surgery has, so far, failed to 
prove its superiority compared to conventional weight loss 
strategies with respect to its impact on the severity of OSA, 
as measured by the apnea-hypopnea-index (20).
Patients who are eligible for bariatric surgery may suffer 
from undiagnosed OSA (21) potentially putting them at risk 
when undergoing general anesthesia (22-27). A meta-analysis 
investigating the association between OSA and post-operative 
complications of any intervention found that the incidence 
of post-operative desaturations, respiratory failure, cardiac 
events and transfers to the intensive care unit was higher in 
patients with untreated OSA (23). 
The standard to diagnose OSA is overnight polysomnography 
(PSG), but this is an expensive and time-intense procedure 
and not widely available (8,28). In contrast, a case-finding 
screening tool often used to classify patients at risk of OSA 
is the STOP-BANG questionnaire (29,30). Combining 
the STOP-BANG questionnaire with the recording of a 
physiological signal, nocturnal pulse oximetry, can help to 
improve diagnostic accuracy (31).
We hypothesized that screening for sleep-disordered breathing 
following STOP-BANG assessment in the pre-bariatric 
population, using nocturnal pulse oximetry as part of the 
assessment, will assist in the diagnosis of patients with 
previously unknown OSA. 
Patients and methods
Screening of bariatric patients
Patients undergoing bariatric surgery at Guy’s & St Thomas’ 
NHS Foundation Trust, London, UK between 12/2013 and 
12/2014 were screened as part of the pre-operative assessment 
using the STOP-BANG questionnaire. STOP-BANG 
is the acronym for snoring [‘does the patient snore loudly 
(loud enough to be heard through closed doors or your 
bed-partner elbows you for snoring at night?)’], tiredness 
(‘does the patient often feel tired, fatigued, or sleepy during the 
daytime?’), observed apnea (‘has anyone observed the patient 
stop breathing or choking/gasping during sleep?’), blood 
pressure (BP) (‘does the patient have or is the patient being 
treated for high BP?’), body mass index (BMI >35 kg/m2), 
age (>50 years), neck circumference (>40 cm), and gender 
(male). Each item scores either ‘0’ (if the answer is no) or ‘1’ (if 
the answer is yes) point. Those who scored >4 points are likely 
to be at risk of OSA and were referred to the Sleep Disorder 
Centre for a comprehensive evaluation. A STOP-BANG 
score of >4 points has been found to have a sensitivity of 88% 
for the diagnosis of OSA (32). 
As part of the evaluation expert sleep physicians assessed 
the patients’ history of the sleep complaint, brief examination, 
recorded weight, height, BP and other co-morbidities and 
measured the epworth sleepiness scale (ESS) (33).
Patient data
Patient demographics included age, sex, BMI, ESS score, 
comorbidities including hypertension, T2DM, depression 
and ischemic heart disease (IHD).
Nocturnal pulse oximetry
Patients underwent nocturnal pulse oximetry (Pulsox 300i, 
Konica Minolta sensing Inc., Hachioji, Tokyo, Japan) for 
two consecutive nights at home. The following data were 
recorded and calculated:
•	 Mean peripheral capillary oxygen saturation (SpO2) 
•	 4% and 3% oxygen desaturation index (ODI, h-1)
•	 Total time with oxygen saturation <90% (percent of 
the total night)
•	 Mean pulse rate (h-1)
•	 Pulse rises [>6 beats per minute (bpm); h-1]
The recorded traces were reviewed and interpreted by 
270 Reed et al. Sleep- disordered breathing in a bariatric population
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2016;8(2):268-275www.jthoracdis.com
an experienced sleep physician. Based on the results of the 
tests the sleep physician provided an interpretation. OSA 
was defined as a 4% ODI of >5 h-1. Severity of OSA was 
classified as mild (4% ODI 5-15 h-1), moderate (4% ODI 
15-30 h-1) and severe (4% ODI >30 h-1) (34).
Treatment decisions for the patient, based on the results 
of the above assessment, included (Figure 1A,B): 
(I) No significant sleep-disordered breathing, no 
action required;
(II) Mild OSA, if the patients were symptomatic 
it was recommended to consider a mandibular 
advancement device for symptom management 
independent of the surgical intervention;
(III) Moderate-severe OSA, trial of CPAP; 
(IV) Extubation onto CPAP advised post-surgery due to 
significant desaturations;
(V) Suggested admission to the sleep center for further 
respiratory assessment, if the results of the pulse 
oximetry were inconclusive.
Statistical analysis
Continuous variables are presented as mean (standard 
deviation) and categorical variables as percentages. For 
unadjusted comparisons between OSA and non-OSA 
patients, continuous variables were compared using an 
unpaired two-tailed t-test. All other categorical variables 
were compared using the Chi-square test. For unadjusted 
comparisons between mild, moderate and severe OSA, 
continuous variables were compared using the Kruskal-Wallis 
one-way ANOVA with Dunnparisons between  multiple 
comparisons. All other categorical variables (class II or III 
obesity, hypertension, T2DM, depression and IHD) were 
compared using Chi-square test. In the univariate analysis 
we compared the dependent variables 4% ODI h-1 (and 3% 
ODI h-1) with other independent variables (gender, age, BMI, 
ESS, class II/III obesity, hypertension, diabetes, IHD, SpO2, 
Time with oxygen saturation <90% (%), pulse rate (h-1) and 
pulse rise (h-1) using a Spearman correlation test. We finally 
performed a multiple linear regression analysis to identify 
the variables that significantly correlated with the dependent 
variables; 3% ODI h-1 and 4% ODI h-1. A P value <0.05 
was assumed to represent statistical significance. 
Results
Demographics
The studied cohort included a total of 141 patients awaiting 
bariatric surgery who scored >4 points on STOP-BANG in 
their pre-operative assessment [70% female, age 49 (±12) years, 
BMI 48.7 (±7.3) kg/m2; Table 1]. Systemic hypertension was 
prevalent in 40%, T2DM was present in 35%, and 25% of the 
patients had depression. The majority of the patients were not 
excessively sleepy [ESS 7.3 (±4.9) points].
Sleep apnea prevalence and treatment recommendations
Sleep-disordered breathing of any degree was evident in 103 of 
141 patients (73%). 13 of 141 patients (9%) were found to 
have severe OSA, 19 of 141 (13%) had moderate OSA and 
34 of 141 (24%) had mild OSA. 12 of 141 (9%) suffered with 
moderate to severe OSA with significant periods of the night 
below SpO2 of 90%, potentially indicating co-existing obesity 
hypoventilation syndrome (OHS) (35).
Based on these findings, 34 of 141 (24%) patients who were 
excessively sleepy were given CPAP prior to surgery and in 5 of 
141 (4%) patients’ extubation to CPAP post-surgery was 
recommended. Fifteen of 141 patients (11%) were admitted for 
further respiratory assessment to the sleep laboratory, and in 
13 of 141 patients (9%) the use of a mandibular advancement 
device was recommended (Figure 1A,B).
Nocturnal pulse oximetry
There were no significant differences in parameters between 
the nocturnal pulse oximetry data on night 1 vs. night 2 
(Table 2). Bariatric patients who had OSA were older (P<0.004), 
more obese (P<0.008), and more sleepy (P<0.05). They had 
more co-morbidities with hypertension (P<0.05) and T2DM 
(P<0.05) (Table 3). A multiple linear regression analysis 
revealed that time with SpO2 saturation <90% (P<0.001), pulse 
rise index (P<0.001) and ESS (P<0.001) were independently 
associated with the oxygen desaturation indices (Table 4). 
Discussion
Patients undergoing bariatric surgery who score >4 on the 
STOP-BANG questionnaire have a high prevalence of 
OSA with almost three quarters of patients having some 
abnormal nocturnal breathing pattern. Approximately 
one quarter of the patients had moderate-severe OSA, 
while 1/10 had a recording that was consistent with 
combined OSA/OHS (35). In more than one quarter 
of all patients CPAP was employed for peri-operative 
management. 11% of the patients were invited for further 
respiratory assessment for an inpatient sleep study in the 
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Patients referred by the bariatric 
service [2014]
N=141
STOP BANG  score >4
Pulse oximetry study
(ODI)
ODI 0-5
No OSA/minor SDB
(n=63)
ODI 5-15
Mild OSA
(n=34)
ODI 15-30
Moderate OSA
(n=19)
ODI >30
Severe OSA  
(n=13)
OSA and  
OHS
(n=12)
ODI 0-5
No OSA/minor SDB (n=63)
Continuous positive airway 
pressure (n=2)
Extubation onto CPAP 
advised post-surgery (n=1)
Mandibular assisted device 
(n=3)
No treatment
(n=57)
ODI 5-15
Mild OSA (n=34)
No treatment (n=19)
Mandibular assisted device 
(n=10)
Continuous positive airway 
pressure (n=1)
Extubation onto CPAP 
advised post-surgery (n=4)
ODI 15-30
Moderate OSA
(n=19)
Admission to the 
sleep centre for 
further respiratory 
assessment (n=1)
Continuous 
positive airway 
pressure
(n=18)
ODI >30
Severe OSA
(n=13)
Admission to the 
sleep centre for 
further respiratory 
assessment (n=5)
Continuous 
positive airway 
pressure (n=8)
OSA and 
OHS (n=12)
Admission to the 
sleep centre for 
further respiratory 
assessment (n=9)
Continuous 
positive airway 
pressure (n=5)*
A
B
Figure 1 Flow diagram of decisional management of bariatric cohort. *, two patients given CPAP and admitted. ODI, oxygen desaturation 
index; SDB, sleep disordered breathing; OSA, obstructive sleep apnea; OHS, obesity hypoventilation syndrome; CPAP, continuous positive 
airway pressure.
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Table 2 Nocturnal pulse oximetry data of the patients studied, 
comparison of night 1 vs. night 2
Nocturnal oximetry Night 1 Night 2 P value
SpO2 (%) 94 (2.8) 93.9 (2.9) 0.79
4% ODI (h-1) 17.1 (25.3) 19 (27.5) 0.09
3% ODI (h-1) 21.6 (27.2) 21.9 (28.1) 0.54
Time with O2 sats <90% (%) 8.9 (17.1) 8.3 (16.3) 0.84
Pulse rate (h-1) 35.3  (12) 35.5 (11.4) 0.91
Pulse rise (h-1; >6 bpm) 75.4 (21.1) 74.9 (20.4) 0.37
There were no significant differences between the nights. The 
results indicated moderate sleep-disordered breathing with 
almost 1/10 of the night below oxygen saturations of 90%, and an 
increased pulse rise index caused by arousal from sleep. All data 
are presented as mean (SD). SpO2, peripheral capillary oxygen 
saturation; ODI, oxygen desaturation index; bpm, beats per minute.
Table 3 Comparison of patients with OSA and those without
Characteristics OSA No OSA P value
Age (years) 48.5 (12.3) 42.0 (10.6) 0.004
BMI (kg/m2) 49.6 (7.8) 46.0 (5.7) 0.008
BMI score 35-39 97.0 (68.7) 35.0 (92.1) 0.65
ESS 7.6 (5.1) 6.0 (4.3) 0.05
Nocturnal oximetry
SpO2 (%) 93.4 (2.9) 96.0 (1.1) <0.001
4% ODI (h-1) 22.3 (27.8) 3.0(1.2) <0.001
3% ODI (h-1) 27.9 (29.5) 4.0 (1.8) <0.001
Time with O2 sats <90% (%) 12.1 (19.0) 0 (0.6) <0.001
Pulse rate (h-1) 75.4 (11.7) 74.0 (8.1) 0.38
Pulse rise (h-1) (>6 bpm) 37.5 (23.0) 31.0 (15.2) 0.06
Co-morbidities
Hypertension 46.0 (44.6) 10.0 (26.3) 0.05
T2DM 40.0 (38.8) 8.0 (21.1) 0.05
Depression 24.0 (23.3) 11.0 (28.9) 0.49
IHD 2.0 (1.9) 1.0 (2.6) 0.73
Hypertension ≥140/90 mmHg. Patients with OSA were older, 
more obese, sleepier and had more comorbidities with 
hypertension and T2DM. BMI, body mass index; ESS, epworth 
sleepiness scale; SpO2, peripheral capillary oxygen saturation; 
ODI, oxygen desaturation index; T2DM, type 2 diabetes mellitus; 
IHD, ischemic heart disease; OSA, obstructive sleep apnea.
Table 4 Spearman correlation between the dependent variables 
(4% ODI and 3% ODI) and other independent variables
Variables 4% ODI 3% ODI
Gender 0.26‡ 0.29†
Age 0.17‡ 0.18‡
BMI (kg/m²) 0.30† 0.28†
ESS (score) 0.28† 0.28‡
Class II obesity 0.06‡ 0.07‡
Class III obesity 0.06‡ 0.07‡
Hypertension 0.18‡ 0.19‡
T2DM 0.16‡ 0.16‡
Depression 0.05‡ 0.04‡
IHD 0.01‡ 0.01‡
SpO2 0.64
† 0.65†
Time with O2 saturation <90% (%) 0.89
† 0.87†
Pulse rate (h-1) 0.28† 0.29†
Pulse rise (h-1) 0.35† 0.36†
Hypertension ≥140/90 mmHg. ‡, P<0.05, †, P<0.001. BMI, body 
mass index; ESS, epworth sleepiness scale; SpO2, peripheral 
capillary oxygen saturation; ODI, oxygen desaturation index; 
T2DM, type 2 diabetes mellitus; IHD, ischemic heart disease.
sleep laboratory (pre-operatively); 9% were recommended 
to use a mandibular advancement device in future for mild 
but symptomatic OSA. Bariatric patients who were more 
obese, older, more sleepy and who had more comorbidities 
(hypertension, diabetes) were more likely to have significant 
sleep-disordered breathing.
Clinical significance of findings
Almost half of the patients were given some recommendation 
for further respiratory management, no further action 
was required for 54% of patients. CPAP is a common and 
effective treatment for OSA (36). It reduces symptoms like 
daytime sleepiness, but it has also been found to improve 
cognitive function (37) and cardiovascular risks (38). As our 
understanding about prevalence in bariatric surgery cohorts 
improves, it is important that we diagnose and treat OSA in 
these patients to reduce peri-operative complications. Our 
study also found that patients with OSA compared to those 
without OSA were older, heavier and sleepier, they were 
also more likely to have hypertension and T2DM. Although 
this is not causal evidence in this small cohort, it supports 
the suggestion that OSA is a risk factor for cardiovascular 
and metabolic conditions (13).
Table 1 Baseline data of the cohort of 141 patients studied
Variables Participants (n=141)
Sex (M:F) 42:99
Age (years) 48.8±(12.2)
BMI (kg/m²) 48.7±(7.3)
ESS (/15) 7.3±(4.9)
Data are presented as mean ± (SD). BMI, body mass index; 
ESS, epworth sleepiness scale.
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Review of literature
Our results are consistent with previous studies describing 
the prevalence of OSA to be 78.3% in patients who have 
bariatric surgery (39), while another study found that 
77% of patients for bariatric surgery had OSA (40). It 
has been reported that patients with OSA who received 
CPAP therapy before surgery have less peri-operative 
complications compared to patients with undiagnosed and 
untreated OSA (25). This underlines the importance to 
diagnose and treat OSA in these patients to reduce the risk 
of complications during and following bariatric surgery.
Data from the national bariatric surgery registry in the UK 
show that in 2006 there were fewer than 500 bariatric surgery 
procedures and that this increased to over 6,000 bariatric 
surgery procedures in 2013 (41), a trend that is mirrored 
the world over. Therefore the number of patients at risk of 
peri-operative complications is increasing and diagnosis and 
treatment of patients with OSA using CPAP could optimize 
peri-operative management.
Limitations of the study
Patients were from a selected cohort, screened using the 
STOP-BANG score, and final outcomes and complications 
after surgery was not recorded, peri-operative risks were not 
assessed. In order to investigate the effectiveness of CPAP 
treatment future studies would need to randomize identified 
cases of patients with OSA undergoing bariatric surgery to a 
trial of CPAP or sham-CPAP peri-operatively. It would also be 
of interest to extend this research to other surgical non-bariatric 
cohorts. Further, the absolute prevalence of OSA in all bariatric 
surgery patients may differ due to the exclusion of patients who 
scored less than four points on the STOP-BANG questionnaire.
Conclusions
There is a high prevalence of sleep-disordered breathing in 
patients undergoing bariatric surgery who score >4 points 
on STOP-BANG. Screening these patients for OSA prior to 
bariatric surgery using nocturnal pulse oximetry and offering 
treatment with CPAP could reduce peri-operative risks.
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